FDA authorizes at-home rapid COVID test

Indonesia Berita Berita

FDA authorizes at-home rapid COVID test
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 axios
  • ⏱ Reading Time:
  • 9 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 63%

It's the FDA's second approval of an at-home COVID test in less than a week as shortages continue.

Siemens Healthineers' Clinitest rapid COVID-19 antigen self-test is authorized for use by anyone over 14 years of age or adult-collected samples from

those age 2 to 13 years, perafter Roche announcedThe Department of Health and Human Services confirmed the approval of the Siemens Healthineers and Roche's tests

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

axios /  🏆 302. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

FDA says rapid Covid antigen tests may be less sensitive in detecting omicronFDA says rapid Covid antigen tests may be less sensitive in detecting omicronCase numbers are surging across the country, prompting high demand for at-home testing kits.
Baca lebih lajut »

FDA says rapid Covid antigen tests may be less sensitive in detecting omicronFDA says rapid Covid antigen tests may be less sensitive in detecting omicronThe Food and Drug Administration said Tuesday that preliminary research shows some rapid antigen tests may be less sensitive at detecting the highly contagious omicron variant of the coronavirus.
Baca lebih lajut »

FDA says rapid COVID-19 antigen tests may be less sensitive in detecting omicronFDA says rapid COVID-19 antigen tests may be less sensitive in detecting omicronThe Food and Drug Administration said Tuesday that preliminary research shows some rapid antigen tests may be less sensitive at detecting the highly contagious
Baca lebih lajut »

Experts Warn Merck's FDA-Authorized Covid Pill Could 'Create Breeding Ground for Mutant Viruses'Experts Warn Merck's FDA-Authorized Covid Pill Could 'Create Breeding Ground for Mutant Viruses''The FDA and Merck have essentially engaged the public in a gamble without public debate,' argues Stanford University's michaelzlin.
Baca lebih lajut »

State will provide 200,000 rapid COVID-19 tests to K-12 employeesState will provide 200,000 rapid COVID-19 tests to K-12 employeesState education are encouraging school personnel to take one of the antigen tests before returning to work after the winter break.
Baca lebih lajut »

Rapid COVID test companies lobby for Medicare coverageRapid COVID test companies lobby for Medicare coverageThe largest makers of rapid, at-home COVID tests have created a new lobbying group to urge Medicare to pay for their tests.
Baca lebih lajut »



Render Time: 2025-03-11 04:15:04